102 related articles for article (PubMed ID: 11997269)
1. Adenylyl cyclase: a new target for heart failure therapeutics.
Feldman AM
Circulation; 2002 Apr; 105(16):1876-8. PubMed ID: 11997269
[No Abstract] [Full Text] [Related]
2. Still stressed out but doing fine: normalization of wall stress is superfluous to maintaining cardiac function in chronic pressure overload.
Sano M; Schneider MD
Circulation; 2002 Jan; 105(1):8-10. PubMed ID: 11772868
[No Abstract] [Full Text] [Related]
3. Adenylyl cyclase increases survival in cardiomyopathy.
Roth DM; Bayat H; Drumm JD; Gao MH; Swaney JS; Ander A; Hammond HK
Circulation; 2002 Apr; 105(16):1989-94. PubMed ID: 11997288
[TBL] [Abstract][Full Text] [Related]
4. Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy.
Roth DM; Gao MH; Lai NC; Drumm J; Dalton N; Zhou JY; Zhu J; Entrikin D; Hammond HK
Circulation; 1999 Jun; 99(24):3099-102. PubMed ID: 10377071
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress.
Esposito G; Rapacciuolo A; Naga Prasad SV; Takaoka H; Thomas SA; Koch WJ; Rockman HA
Circulation; 2002 Jan; 105(1):85-92. PubMed ID: 11772881
[TBL] [Abstract][Full Text] [Related]
6. Of phospholamban, mice, and humans with heart failure.
Bristow M
Circulation; 2001 Feb; 103(6):787-8. PubMed ID: 11171783
[No Abstract] [Full Text] [Related]
7. Inhibition of betaARK1 restores impaired biochemical beta-adrenergic receptor responsiveness but does not rescue CREB(A133) induced cardiomyopathy.
Eckhart AD; Fentzke RC; Lepore J; Lang R; Lin H; Lefkowitz RJ; Koch WJ; Leiden JM
J Mol Cell Cardiol; 2002 Jun; 34(6):669-77. PubMed ID: 12054854
[TBL] [Abstract][Full Text] [Related]
8. Defective beta-adrenergic receptor signaling precedes the development of dilated cardiomyopathy in transgenic mice with calsequestrin overexpression.
Cho MC; Rapacciuolo A; Koch WJ; Kobayashi Y; Jones LR; Rockman HA
J Biol Chem; 1999 Aug; 274(32):22251-6. PubMed ID: 10428792
[TBL] [Abstract][Full Text] [Related]
9. Interplay between the E2F pathway and β-adrenergic signaling in the pathological hypertrophic response of myocardium.
Major JL; Salih M; Tuana BS
J Mol Cell Cardiol; 2015 Jul; 84():179-90. PubMed ID: 25944088
[TBL] [Abstract][Full Text] [Related]
10. Transgenic replacement of type V adenylyl cyclase identifies a critical mechanism of beta-adrenergic receptor dysfunction in the G alpha q overexpressing mouse.
Tepe NM; Liggett SB
FEBS Lett; 1999 Sep; 458(2):236-40. PubMed ID: 10481072
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of myocardial Gsalpha prevents full expression of catecholamine desensitization despite increased beta-adrenergic receptor kinase.
Vatner DE; Asai K; Iwase M; Ishikawa Y; Wagner TE; Shannon RP; Homcy CJ; Vatner SF
J Clin Invest; 1998 May; 101(9):1916-22. PubMed ID: 9576756
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of impaired beta-adrenergic receptor signaling in G(alphaq)-mediated cardiac hypertrophy and ventricular dysfunction.
Dorn GW; Tepe NM; Wu G; Yatani A; Liggett SB
Mol Pharmacol; 2000 Feb; 57(2):278-87. PubMed ID: 10648637
[TBL] [Abstract][Full Text] [Related]
13. Reduced beta-adrenergic receptor activation decreases G-protein expression and beta-adrenergic receptor kinase activity in porcine heart.
Ping P; Gelzer-Bell R; Roth DA; Kiel D; Insel PA; Hammond HK
J Clin Invest; 1995 Mar; 95(3):1271-80. PubMed ID: 7883975
[TBL] [Abstract][Full Text] [Related]
14. Localization of a "postreceptor" defect in human dilated cardiomyopathy.
Böhm M; Gierschik P; Jakobs KH; Schnabel P; Kemkes B; Erdmann E
Am J Cardiol; 1989 Oct; 64(12):812-4. PubMed ID: 2552787
[No Abstract] [Full Text] [Related]
15. Functionally active targeting domain of the beta-adrenergic receptor kinase: an inhibitor of G beta gamma-mediated stimulation of type II adenylyl cyclase.
Inglese J; Luttrell LM; Iñiguez-Lluhi JA; Touhara K; Koch WJ; Lefkowitz RJ
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3637-41. PubMed ID: 8170960
[TBL] [Abstract][Full Text] [Related]
16. What is the role of beta-adrenergic signaling in heart failure?
Lohse MJ; Engelhardt S; Eschenhagen T
Circ Res; 2003 Nov; 93(10):896-906. PubMed ID: 14615493
[TBL] [Abstract][Full Text] [Related]
17. cAMP-mediated beta-adrenergic signaling negatively regulates Gq-coupled receptor-mediated fetal gene response in cardiomyocytes.
Patrizio M; Vago V; Musumeci M; Fecchi K; Sposi NM; Mattei E; Catalano L; Stati T; Marano G
J Mol Cell Cardiol; 2008 Dec; 45(6):761-9. PubMed ID: 18851973
[TBL] [Abstract][Full Text] [Related]
18. Beta-adrenergic signal transduction following carvedilol treatment in hypertensive cardiac hypertrophy.
Böhm M; Ettelbrück S; Flesch M; van Gilst WH; Knorr A; Maack C; Pinto YM; Paul M; Teisman AC; Zolk O
Cardiovasc Res; 1998 Oct; 40(1):146-55. PubMed ID: 9876327
[TBL] [Abstract][Full Text] [Related]
19. New insight into the role of enhanced adrenergic receptor-effector coupling in the heart.
Feldman AM; McTiernan C
Circulation; 1999 Aug; 100(6):579-82. PubMed ID: 10441092
[No Abstract] [Full Text] [Related]
20. Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(salpha) mouse.
Asai K; Yang GP; Geng YJ; Takagi G; Bishop S; Ishikawa Y; Shannon RP; Wagner TE; Vatner DE; Homcy CJ; Vatner SF
J Clin Invest; 1999 Sep; 104(5):551-8. PubMed ID: 10487769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
